Microba Life Sciences Ltd Financial Flexibility Index
Microba Life Sciences Ltd financial flexibility index. Microba Life Sciences Ltd (MAP) has a Financial Flexibility Index of -0.45x as of December 2025. Free cash flow of AU$-5.51 Million (operating CF AU$-5.70 Million minus capex AU$189.71K) represents 0% of total liabilities (AU$12.27 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Microba Life Sciences Ltd (2018–2024)
Financial flexibility index of Microba Life Sciences Ltd from 2018 to 2024. Historical Financial Flexibility Index trend for Microba Life Sciences Ltd across 7 annual periods. Explore MAP operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Microba Life Sciences Ltd Financial Flexibility Index by Year (2018–2024)
Microba Life Sciences Ltd financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Microba Life Sciences Ltd. For the full cash flow conversion analysis, see Microba Life Sciences Ltd (MAP) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.61x | AU$-9.11 Million | AU$-12.01 Million | AU$14.94 Million | ▲ +8.3% |
| 2023 | -0.66x | AU$-11.19 Million | AU$-15.57 Million | AU$16.82 Million | ▲ +41.5% |
| 2022 | -1.14x | AU$-9.36 Million | AU$-12.39 Million | AU$8.23 Million | ▲ +21.2% |
| 2021 | -1.44x | AU$-8.58 Million | AU$-10.45 Million | AU$5.94 Million | ▲ +21.3% |
| 2020 | -1.83x | AU$-6.51 Million | AU$-7.18 Million | AU$3.55 Million | ▼ -64.1% |
| 2019 | -1.12x | AU$-3.47 Million | AU$-4.32 Million | AU$3.10 Million | ▲ +42.5% |
| 2018 | -1.94x | AU$-2.78 Million | AU$-3.62 Million | AU$1.43 Million | — |